A lawsuit has been filed by opponents of cannabis reform, challenging the federal cannabis rescheduling of medical products from Schedule I to Schedule II…
Access & Prescribing (Australia & Global)
Medicinal Cannabis Explored for Endometriosis Pain Management
Explore how medicinal cannabis is being considered for managing the chronic pelvic pain of endometriosis, offering a potential option where traditional tr…
Australian Cannabis Policy & Law
Bavarian Court Ruling Clarifies Industrial Hemp Legality in Germany, Ending “Intoxication Clause” Prosecutions
A Bavarian court ruling has provided legal clarity for Germany's industrial hemp sector, impacting cultivation permits and trade. Learn how the Amberg Dis…
Australian Cannabis Policy & Law
Medicinal Cannabis Research Poised for Expansion Following Rescheduling Discussions
Explore how the potential rescheduling of cannabis to Schedule III could significantly expand medicinal cannabis research, enabling more rigorous clinical…
Access & Prescribing (Australia & Global)
Nebraska Medical Cannabis Program Implementation Remains Stalled Amidst Ongoing Public Forums
Explore the current status of the Nebraska medical cannabis program, 18 months after voter approval. Learn why implementation remains stalled despite publ…
Equities, Investment & Market Trends
DEA Prepares to Launch Schedule III Cannabis Registration Portal for Non-Dispensary Businesses
The DEA is set to launch a dedicated Schedule III cannabis registration portal for cultivators, manufacturers, and labs. Understand the new process, fees,…
Industrial Hemp & Advanced Manufacturing
Panda Biotech and Culturewell Partner to Bring US Hemp Fibre to India’s Textile Industry
Discover how Panda Biotech and Culturewell's partnership is bringing US-grown hemp fibre to India, meeting the textile industry's demand for sustainable,…
Access & Prescribing (Australia & Global)
Medical Cannabis Events Evolve: Cape to Cape for Cannabis Blends Clinical Education with Outdoor Engagement
Discover how the Cape to Cape for Cannabis event in Western Australia is reshaping medical cannabis events, combining clinical education with outdoor acti…
Access & Prescribing (Australia & Global)
New Hampshire Medical Cannabis Program Sees Significant Patient Growth Following Policy Changes
New Hampshire's medical cannabis program expanded by over 2,100 patients last year, reaching nearly 17,000 total. Discover how policy adjustments in 2024…
Access & Prescribing (Australia & Global)
Navigating Medicinal Cannabis Access and Evidence in Australia: A Clinical Perspective
Explore the evolving landscape of medicinal cannabis in Australia, examining clinical evidence, access pathways, and expert perspectives on its role in pa…
